You searched for "natural killer"
-
NK – Human Natural Killer CellsHuman Natural Killer Cells pos selection, ≥5 million cellsCatalog #: 2W-502Sales unit: eachCompareSave to list Save to list
-
NK - Human Natural Killer Cells, Cryopreserved, Negative Selection, 5 Million
Crypreserved ampule of Peripheral Blood Human Natural Killer Cells (CD56 negative immunomagnetic selection) containing ≥ 5 million cells
Catalog #: 2W-501Sales unit: eachCompareSave to list Save to list -
Human Peripheral Blood CD4+ T Cells, Cryopreserved, 10 Million
Cryopreserved ampule of Human Peripheral Blood CD4+ T Cells containing ≥10 million cells, negatively selected.
Catalog #: 2W-200Sales unit: eachCompareSave to list Save to list -
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 millionCryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cellsCatalog #: CC-2702Sales unit: eachCompareSave to list Save to list
-
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Catalog #: CC-2703Sales unit: AmpuleCompareSave to list Save to list -
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 25 million
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Catalog #: CC-2705Sales unit: AmpuleCompareSave to list Save to list -
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 10 million
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Catalog #: CC-2704Sales unit: AmpuleCompareSave to list Save to list -
Cryo Human Leukopak (9.5 Billion Cells)
Cryopreserved human leukapheresis product (≥9.5 billion cells)
Catalog #: 260240.01Sales unit: BagCompareSave to list Save to list -
Cryo Human Leukopak (5.0 Billion Cells)
Cryopreserved human leukapheresis product (≥5.0 billion cells)
Catalog #: 260260.01Sales unit: BagCompareSave to list Save to list -
Cryo Human Leukopak (2.5 Billion Cells)Cryopreserved human leukapheresis product collected from normal peripheral blood, containing ≥2.5 billion cellsCatalog #: 260280.01Sales unit: BagCompareSave to list Save to list
-
Fresh Human Leukopak (5 Billion Cells)Fresh human leukopheresis product collected from normal peripheral blood, containing ≥ 5 billion cellsCatalog #: 3P-105BSales unit: eachCompareSave to list Save to list
-
Fresh Human Leukopak (10 Billion Cells)Fresh human leukapheresis product collected from normal peripheral blood, containing ≥ 10 billion cellsCatalog #: 3P-105Sales unit: eachCompareSave to list Save to list
-
Human Peripheral Blood CD8+ T Cells, Cryopreserved, 10 million cells
Cryopreserved ampule of Human Peripheral Blood CD8+ T Cells containing 10 million cells
Catalog #: 2W-300Sales unit: AmpuleCompareSave to list Save to list
You searched for "natural killer"
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion/Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
RAFT™ 3D Cell Culture System – ApplicationsThis presentation provides an overview of the various applications for which the RAFT™ 3D Cell Culture System has been used including the creation of cancer, corneal, airway, skin or blood brain barrier models.
-
References - X-Vivo™Overview of relevant references
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
-
Primary Cells and Media Reference GuideA comprehensive collection of Lonza primary cell and media products supporting many research areas.
-
Application ExampleAnalysis of undirected migration of NK cells
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content. New in print
-
Brochure - Cell ListIntegrated solutions for primary cells and transfection